Mutations In the Tet Oncogene Family Member 2 (TET2) Gene Refine the New European LeukemiaNet Risk Classification of Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) In Adults: A Cancer and Leukemia Group B (CALGB) Study
Publication
, Conference
Metzeler, KH; Maharry, K; Radmacher, MD; Mrozek, K; Margeson, D; Becker, H; Curfman, J; Holland, KB; Schwind, S; Whitman, SP; Wu, Y-Z; Blum, W ...
Published in: BLOOD
November 19, 2010
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 19, 2010
Volume
116
Issue
21
Start / End Page
48 / 49
Location
Orlando, FL
Publisher
AMER SOC HEMATOLOGY
Conference Name
52nd Annual Meeting of the American-Society-of-Hematology (ASH)
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Metzeler, K. H., Maharry, K., Radmacher, M. D., Mrozek, K., Margeson, D., Becker, H., … Bloomfield, C. D. (2010). Mutations In the Tet Oncogene Family Member 2 (TET2) Gene Refine the New European LeukemiaNet Risk Classification of Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) In Adults: A Cancer and Leukemia Group B (CALGB) Study. In BLOOD (Vol. 116, pp. 48–49). Orlando, FL: AMER SOC HEMATOLOGY.
Metzeler, Klaus H., Kati Maharry, Michael D. Radmacher, Krzysztof Mrozek, Dean Margeson, Heiko Becker, John Curfman, et al. “Mutations In the Tet Oncogene Family Member 2 (TET2) Gene Refine the New European LeukemiaNet Risk Classification of Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) In Adults: A Cancer and Leukemia Group B (CALGB) Study.” In BLOOD, 116:48–49. AMER SOC HEMATOLOGY, 2010.
Metzeler KH, Maharry K, Radmacher MD, Mrozek K, Margeson D, Becker H, et al. Mutations In the Tet Oncogene Family Member 2 (TET2) Gene Refine the New European LeukemiaNet Risk Classification of Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) In Adults: A Cancer and Leukemia Group B (CALGB) Study. In: BLOOD. AMER SOC HEMATOLOGY; 2010. p. 48–9.
Metzeler, Klaus H., et al. “Mutations In the Tet Oncogene Family Member 2 (TET2) Gene Refine the New European LeukemiaNet Risk Classification of Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) In Adults: A Cancer and Leukemia Group B (CALGB) Study.” BLOOD, vol. 116, no. 21, AMER SOC HEMATOLOGY, 2010, pp. 48–49.
Metzeler KH, Maharry K, Radmacher MD, Mrozek K, Margeson D, Becker H, Curfman J, Holland KB, Schwind S, Whitman SP, Wu Y-Z, Blum W, Powell BL, Carter TH, Wetzler M, Moore JO, Kolitz JE, Baer MR, Carroll AJ, Larson RA, Caligiuri MA, Marcucci G, Bloomfield CD. Mutations In the Tet Oncogene Family Member 2 (TET2) Gene Refine the New European LeukemiaNet Risk Classification of Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) In Adults: A Cancer and Leukemia Group B (CALGB) Study. BLOOD. AMER SOC HEMATOLOGY; 2010. p. 48–49.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 19, 2010
Volume
116
Issue
21
Start / End Page
48 / 49
Location
Orlando, FL
Publisher
AMER SOC HEMATOLOGY
Conference Name
52nd Annual Meeting of the American-Society-of-Hematology (ASH)
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology